Mendler, J. H., Maharry, K., Radmacher, M. D., Mrozek, K., Kohlschmidt, J., Nicolet, D., … Bloomfield, C. D. (2011). Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures. In BLOOD (Vol. 118, pp. 1476–1477). San Diego, CA: AMER SOC HEMATOLOGY.

Mendler, Jason H., Kati Maharry, Michael D. Radmacher, Krzysztof Mrozek, Jessica Kohlschmidt, Deedra Nicolet, Heiko Becker, et al. “Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures.” In BLOOD, 118:1476–77. AMER SOC HEMATOLOGY, 2011.

Mendler JH, Maharry K, Radmacher MD, Mrozek K, Kohlschmidt J, Nicolet D, et al. Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 1476–7.

Mendler, Jason H., et al. “Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 1476–77.

Mendler JH, Maharry K, Radmacher MD, Mrozek K, Kohlschmidt J, Nicolet D, Becker H, Metzeler KH, Schwind S, Whitman SP, Blum W, Powell BL, Kolitz JE, Carter TH, Wetzler M, Moore JO, Carroll AJ, Baer MR, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD. Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 1476–1477.